The Patent Finder

Amgen Fremont Inc.

6 patents currently held · Updated Nov 21, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Abgenix, Inc. (to 2006)

5
Ending by 2030
Feb 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 29, 2027
    The maintenance fee for Human Monoclonal Antibodies to Activin Receptor-Like KINASE-1 (US 9,221,915) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
  • 1 fee due Jul 19, 2027
    The maintenance fee for Nucleic Acids Encoding Antibodies to CCR2 (US 9,238,691) comes due Jul 19, 2027. Unpaid by Jan 19, 2028, it lapses early.
  • 1 fee due Nov 3, 2027
    The maintenance fee for Human Antibodies That Bind Human Madcam (US 9,328,169) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 6 of 6

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US RE45,847Antibodies to Madcam
In force
 · Low confidence
In forceLow confidence
US 8,080,646Human Monoclonal Antibodies to Activin Receptor-Like KINASE-1
In force
 · High confidence
In forceHigh confidence
US 7,585,500Fully Human Monoclonal Antibodies to IL-13
In force
 · High confidence
In forceHigh confidence
US 9,221,915Human Monoclonal Antibodies to Activin Receptor-Like KINASE-1
In force
 · High confidence
In forceHigh confidence
US 9,238,691Nucleic Acids Encoding Antibodies to CCR2
In force
 · High confidence
In forceHigh confidence
US 9,328,169Human Antibodies That Bind Human Madcam
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 6: 3 patents in force now held by others · 37 lapsed for an unpaid fee · 67 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

13 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited